These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Achilles SL; Shete PB; Whaley KJ; Moench TR; Cone RA Sex Transm Dis; 2002 Nov; 29(11):655-64. PubMed ID: 12438901 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety. Wilson SS; Cheshenko N; Fakioglu E; Mesquita PM; Keller MJ; Herold BC Antivir Ther; 2009; 14(8):1113-24. PubMed ID: 20032541 [TBL] [Abstract][Full Text] [Related]
10. New candidate biomarkers in the female genital tract to evaluate microbicide toxicity. Fields S; Song B; Rasoul B; Fong J; Works MG; Shew K; Yiu Y; Mirsalis J; D'Andrea A PLoS One; 2014; 9(10):e110980. PubMed ID: 25333937 [TBL] [Abstract][Full Text] [Related]
11. Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety. Segarra TJ; Fakioglu E; Cheshenko N; Wilson SS; Mesquita PM; Doncel GF; Herold BC PLoS One; 2011; 6(11):e27675. PubMed ID: 22096611 [TBL] [Abstract][Full Text] [Related]
12. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection. Lebratti T; Lim YS; Cofie A; Andhey P; Jiang X; Scott J; Fabbrizi MR; Ozantürk AN; Pham C; Clemens R; Artyomov M; Dinauer M; Shin H Elife; 2021 May; 10():. PubMed ID: 34047696 [TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Fichorova RN; Bajpai M; Chandra N; Hsiu JG; Spangler M; Ratnam V; Doncel GF Biol Reprod; 2004 Sep; 71(3):761-9. PubMed ID: 15128598 [TBL] [Abstract][Full Text] [Related]
14. Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety. Nixon B; Jandl T; Teller RS; Taneva E; Wang Y; Nagaraja U; Kiser PF; Herold BC Antimicrob Agents Chemother; 2014; 58(2):1153-60. PubMed ID: 24323471 [TBL] [Abstract][Full Text] [Related]
15. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Roy S; Gourde P; Piret J; Désormeaux A; Lamontagne J; Haineault C; Omar RF; Bergeron MG Antimicrob Agents Chemother; 2001 Jun; 45(6):1671-81. PubMed ID: 11353610 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. Shankar GN; Alt C J Antimicrob Chemother; 2014 Dec; 69(12):3282-93. PubMed ID: 25139839 [TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography for assessment of microbicide safety in a small animal model. Bell BA; Vincent KL; Bourne N; Vargas G; Motamedi M J Biomed Opt; 2013 Apr; 18(4):046010. PubMed ID: 23588808 [TBL] [Abstract][Full Text] [Related]
18. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. Herbst-Kralovetz MM; Pyles RB J Virol; 2006 Oct; 80(20):9988-97. PubMed ID: 17005677 [TBL] [Abstract][Full Text] [Related]
19. Clinical development of microbicides for the prevention of HIV infection. D'Cruz OJ; Uckun FM Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390 [TBL] [Abstract][Full Text] [Related]
20. The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment. Seay K; Khajoueinejad N; Zheng JH; Kiser P; Ochsenbauer C; Kappes JC; Herold B; Goldstein H J Virol; 2015 Sep; 89(18):9559-70. PubMed ID: 26157126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]